August 29, 2021
2 mins read

ICMR releases new study on Covaxin doses

The antibody responses of individuals with confirmed pre-vaccination SARS-CoV-2 infection were compared with those individuals without prior evidence of infection…reports Asian Lite News.

A single-dose of Covaxin provides a similar immunity response in previously Covid-infected people as those without previous history of Covid infection with two doses of vaccine, says Indian Council of Medical Research’s latest study.

The ICMR in its recent study has found that the people already infected with Covid-19 while taking a dose of Covaxin have the same or increased antibody response as unaffected people taking two doses of Covaxin.

The pilot study was undertaken to examine SARS-CoV-2 specific antibody responses after day 0 (baseline before vaccination), day 28A2 days post-first dose (month 1) and day 56A2 days post-first dose (month 2) of BBV152 in a group of healthcare professionals as well as frontline workers.

The antibody responses of individuals with confirmed pre-vaccination SARS-CoV-2 infection were compared with those individuals without prior evidence of infection.

The blood specimens were collected from healthcare professionals and frontline workers who received BBV152 vaccine at vaccination centres in Chennai, India, during February to May 2021.

Blood samples were collected before receiving the first dose of BBV152. Prior infection with SARS-CoV-2 was determined by SARS-CoV-2 IgG positivity at baseline. The study was approved by the Ethics Committee of ICMR-NIRT.

Antibody levels were measured at three time points: on the day of vaccination (baseline), at month one following the first dose and at month two following the first dose.

https://www.youtube.com/watch?v=ngCvDWwuEgM

The results were determined via a calibration curve, which is an instrument specifically generated by two-point calibration and a master curve provided via the reagent QR code.

Almost all participants with prior Covid-19 infection except two had detectable antibodies at the time of vaccination. This study offers evidence in support of public health-oriented and immunologically sustained vaccine strategies.

Lokesh Sharma, Scientist and Media Coordinator, ICMR, says, “This is a pilot study. If such findings are confirmed in large population studies, a single dose of BBV152 vaccine may be recommended to previously confirmed Covid patients so that the naA-ve individuals could attain the larger benefit of a limited vaccine supply.”

ALSO READ-ICMR issues guidance on COVID 19 death cases

READ MORE-No compromise on Covaxin quality, says Bharat Biotech

Previous Story

Indigenously built ‘Vigraha’ commissioned into Coast Guard

Next Story

India administers record 10 million vax doses in a day

Latest from -Top News

UAE-India pact fuels future biz leaders

MoU between ADSM and UIBC-UC to foster entrepreneurship, mentorship, and collaborative research between UAE and India through 2028 In a landmark partnership aimed at cultivating the next generation of global business leaders,

‘1,563 Indians deported from US so far’

Though the ministry did not specify the reasons behind the deportations, the figure reflects a sharp uptick in removals under the Trump administration’s renewed focus on immigration enforcement…reports Asian Lite News More

Why TRF’s Terror Tag Matters

This wasn’t just counterterror—it was a signal. India fused intel, precision strikes, and tech for a swift, strategic blow. TRF wasn’t just named—it was hit….writes John Spencer  Today, July 17, 2025, the

Jaishankar Hails TRF Terror Tag

The US Secretary of State, Marco Rubio, made the official announcement on Thursday…reports Asian Lite News Reacting to the US designating The Resistance Front (TRF), a proxy of Lashkar-e-Taiba (LeT), as a
Go toTop